Approval · Notice of Compliance 36360 · 2025
ORENCIA: Notice of Compliance 36360
Issued November 4, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36360
- Date
- November 4, 2025
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of manufacturing facilities for the drug product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORENCIA | Not yet assigned | — |